Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1481-1490 of 1766 for cancer

Edit search filters
  1. A Study To Evaluate Hormone Concentrations In Patients With Metastatic Cancer

    Rochester, MN

  2. A Study to Evaluate the Safety of the Goldilocks Procedure with Implant-Based Reconstruction

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Circulating Tumor DNA In Endometrial Cancer

    Rochester, MN

  4. A Study Of Healthy Donor Volunteers To Provide Blood Components Via Leukapheresis For In Vitro Dendritic Cell Investigations

    Scottsdale/Phoenix, AZ

  5. Establishment of a Biorepository of Baseline and Follow-up Saliva Samples Collected from Newly Diagnosed, Treatment-naïve Cancer Patients

    Jacksonville, FL

  6. A Study To Evaluate Immune Markers In Patients With Renal Cell Cancer

    Rochester, MN

  7. Evaluation Of A Mixed Meal Test For Diagnosis And Characterization And Type 3c Diabetes Mellitus Secondary To Pancreatic Cancer And Chronic Pancreatitis (DETECT)

    Rochester, MN

  8. Return of Results of Pharmacogenomic Testing for Genes Involved in Metabolism of 5FU and Capecitibine

    Rochester, MN

  9. A Study To Increase Understanding About Pancreatic Cancer Genetics And Response To Drug Therapy

    Rochester, MN

  10. A Study of Clinical Outcomes Associated with Lenvatinib Treatment in Patients with Anaplastic Thyroid Cancer

    Rochester, MN

.

Mayo Clinic Footer